Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer

Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA
Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer ( Dr Mohamed Salem - Levine Cancer Institute, Charlotte, USA )
20 Jul 2022

Prostate cancer screening: A novel risk prediction tool with standard biopsies vs PSA with MRI-targeted biopsies

Dr Lars Björnebo - The Karolinska Institute, Solna, Sweden
Prostate cancer screening: A novel risk prediction tool with standard biopsies vs PSA with MRI-targeted biopsies ( Dr Lars Björnebo - The Karolinska Institute, Solna, Sweden )
20 Jul 2022

Low-dose nivolumab leads to improved overall survival for head and neck cancer patients

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Low-dose nivolumab leads to improved overall survival for head and neck cancer patients ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
19 Jul 2022

Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
19 Jul 2022

Updates from the PROpel and MAGNITUDE studies

Prof Phil Cornford and Dr Elena Castro
Updates from the PROpel and MAGNITUDE studies ( Prof Phil Cornford and Dr Elena Castro )
11 Jul 2022

Update on the latest in PARP inhibitors for prostate cancer

Prof Axel Merseburger and Prof Bertrand Tombal
Update on the latest in PARP inhibitors for prostate cancer ( Prof Axel Merseburger and Prof Bertrand Tombal )
11 Jul 2022

Isatuximab + Pd in Difficult-to-Treat Patients with RRMM

Dr Maximilian Merz - Leipzig University, Leipzig, Germany
Isatuximab + Pd in Difficult-to-Treat Patients with RRMM ( Dr Maximilian Merz - Leipzig University, Leipzig, Germany )
11 Jul 2022

ASCO Direct Highlights 2022: prostate cancer highlights

Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA
ASCO Direct Highlights 2022: prostate cancer highlights ( Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA )
9 Jul 2022

ASCO Direct Highlights 2022: lung cancer highlights

Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA
ASCO Direct Highlights 2022: lung cancer highlights ( Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA )
9 Jul 2022

Locally and advanced immunotherapy developments and new agents in lung cancer

Dr George Simon - Moffitt Advent Health Clinical Research Unit, Tampa, USA
Locally and advanced immunotherapy developments and new agents in lung cancer ( Dr George Simon - Moffitt Advent Health Clinical Research Unit, Tampa, USA )
9 Jul 2022

The advances in the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma

Dr Eduardo Sotomayor - H. Lee Moffitt Cancer Center & Research Institute, Florida, USA
The advances in the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma ( Dr Eduardo Sotomayor - H. Lee Moffitt Cancer Center & Research Institute, Florida, USA )
9 Jul 2022

Diversity and inclusion in oncological care

Dr Vedner Guerrier - Memorial Healthcare System, Hollywood, USA
Diversity and inclusion in oncological care ( Dr Vedner Guerrier - Memorial Healthcare System, Hollywood, USA )
9 Jul 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation